GNRHR and neoplasm: We also analyzed the expression of GnRH receptor in GBM tumor tissue using immunohistochemistry (IHC) analysis using FFPE tissue sections and found the ‘strong’ expression in four out of ten (40%) GBM cases while all the non-tumor controls (epilepsy cases) showed ‘negative’ expression (Supplementary Table S2).